AI-generated analysis. Always verify with the original filing.
Protara Therapeutics, Inc. furnished a press release dated March 10, 2026, under Item 2.02 as Exhibit 99.1, relating to results of operations. This disclosure is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.
Event Type
Disclosure
Mandatory
Variant
8-K
, including the attached Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934,
. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated March 10, 2026, issued by the Registrant. 104 Cover Page Inte